Clinical features of infantile subcutaneous panniculitis-like T-cell lymphoma

Pediatr Int. 2019 Dec;61(12):1261-1262. doi: 10.1111/ped.14017. Epub 2019 Dec 6.

Authors

Hironori Goto¹, Naoki Hirano¹, Hiroko Kadowaki², Souichi Suenobu^{1

3}, Kenji Ihara¹

Affiliations

¹ Department of Pediatrics, Oita University Faculty of Medicine, Yufu, Japan.
² Department of Diagnostic Pathology, Oita University Faculty of Medicine, Yufu, Japan.
³ Division of General Pediatrics and Emergency Medicine, Department of Pediatrics, Oita University Faculty of Medicine, Yufu, Japan.

PMID: 31808238
DOI: 10.1111/ped.14017

No abstract available

Keywords: HLH; PSL; Prognosis; SPTCL; infant.

Publication types

Case Reports

MeSH terms

Administration, Oral
Antineoplastic Agents / administration & dosage*
Child, Preschool
Female
Humans
Infant
Japan
Lymphohistiocytosis, Hemophagocytic / pathology
Lymphoma, T-Cell / drug therapy*
Lymphoma, T-Cell / pathology
Male
Panniculitis / drug therapy*
Panniculitis / pathology
Prednisolone / administration & dosage*
Prognosis
Review Literature as Topic
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Treatment Outcome

Substances

Antineoplastic Agents
Prednisolone

Supplementary concepts

Subcutaneous panniculitis-like T-cell lymphoma